Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

Christian blogger mom who scammed thousands with bogus cancer story is back in the spotlight - ‘[S]he’s an actor,’ retired ...

Amanda Christine Riley defrauded people with a fake cancer scheme — now, her elaborate hoax is the subject of a new ...

The Desert Dogs host Tucker Out Lymphoma Night on Feb. 1, honoring Coach Shawn Williams' late son, Tucker, and raising funds for pediatric cancer.

We report herein a case of thyroid mucosa-associated lymphoid tissue (MALT) lymphoma in a patient receiving antithyroid drug therapy for Graves' disease. A 75-year-old woman first presented with ...

IDEXX Laboratories shared earlier this month the launch of IDEXX Cancer Dx, a diagnostic panel with early detection of ...

MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

This is the second game in the Tucker Out Lymphoma Cup and the Desert Dogs’ annual Tucker Out Lymphoma Night. The night is ...

By Daniella Parra March Biosciences was granted an orphan drug designation from the FDA to MB-105, its CD5-targeted CAR-T ...

Our goal is to help find better treatment and ultimately cure cancer. Cancer affects so many people and lives,” said Devin Smith.

Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.